Session Information
Session Type: Poster Session A
Session Time: 10:30AM-12:30PM
Background/Purpose: The interleukin (IL)-23/IL-17 pathway is central to axial spondyloarthritis (axSpA) pathogenesis, yet treatments targeting IL-23 show inconsistent effectiveness across spondyloarthritis subtypes. We hypothesized that the IL-23/IL-17 axis varies with disease stage and is influenced by regulatory counterparts, such as type 1 regulatory T (Tr1) cells.
Methods: We assessed the levels of IL-17A and IL-23 in serum and the fraction of CD4+IL-17A+ cells, monocytes (CD14+HLR-DR+), DCs (CD11c+HLA-DR+), and type 1 regulatory T cells (Tr1, CD4+CD49b+LAG3+FoxP3–IL-10+) in peripheral blood obtained from patients with axSpA using enzyme-linked immunosorbent assay and flow cytometry. We also assessed the production of IL-17A from CD4+ T cells from healthy controls following co-culture with monocyte-derived DCs (moDCs) from patients with nr-axSpA compared with those from patients with r-axSpA.
Results: Blood samples from 20 nr-axSpA and 24 r-axSpA patients were analyzed. Serum IL-23 was significantly higher in nr-axSpA patients (p = 0.014), while IL-17A was similar in both groups (p = 0.792). Monocytes and DCs from nr-axSpA produced more IL-23 (p = 0.028 for monocyte, and p = 0.010 for DC), but there were no significant differences in Th17 cells between the groups (p > 0.05). moDCs from nr-axSpA patients stimulated higher proinflammatory cytokine production in CD4+ T cells from healthy controls compared to those from r-axSpA (p < 0.05). Notably, Tr1 cells were significantly lower in nr-axSpA (p = 0.025), and IL-10 treatment reduced IL-23 production by moDCs from nr-axSpA but not from r-axSpA.
Conclusion: IL-23 might play a pathogenic role only in the early disease of axSpA, and IL-17 might be dissociated from IL-23 in advanced disease with enhanced IL-10 producing Tr1 cells as a regulatory counterpart, which requires further elucidation.
To cite this abstract in AMA style:
Yeo J, Kim M, Kwon H, Seo M, Choi H, Jung Y, Lee E, Baek H. Stage-Specific Roles of Interleukin-23/Interleukin-17 Axis and Type 1 Regulatory T Cells Dynamics in Axial Spondyloarthritis [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/stage-specific-roles-of-interleukin-23-interleukin-17-axis-and-type-1-regulatory-t-cells-dynamics-in-axial-spondyloarthritis/. Accessed .« Back to ACR Convergence 2024
ACR Meeting Abstracts - https://acrabstracts.org/abstract/stage-specific-roles-of-interleukin-23-interleukin-17-axis-and-type-1-regulatory-t-cells-dynamics-in-axial-spondyloarthritis/